Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

EVP, Strategy & Innovation

PRESIDENT & CEO

Chief Medical Officer

Chief Financial Officer

EVP, Drug Discovery

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, a Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epileptic encephalopathy; and XEN1101, a Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurolog...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-08	Premium	sold	Premium	Premium	Premium	-
2024-03-08	Premium	acquired	Premium	Premium	Premium	-
2024-03-08	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-03-07	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Strategy & Innovation
2024-03-07	Premium	acquired	Premium	Premium	Premium	EVP, Strategy & Innovation
2024-03-07	Premium	sold	Premium	Premium	Premium	-
2024-03-07	Premium	sold	Premium	Premium	Premium	EVP, Strategy & Innovation
2023-12-29	Premium	sold	Premium	Premium	Premium	EVP, Strategy & Innovation
2023-12-19	Premium	acquired	Premium	Premium	Premium	-
2023-12-14	Premium	sold	Premium	Premium	Premium	-
2023-12-13	Premium	sold	Premium	Premium	Premium	-
2023-12-13	Premium	sold	Premium	Premium	Premium	-
2023-12-13	Premium	sold (taxes)	Premium	Premium	Premium	-
2023-12-13	Premium	acquired	Premium	Premium	Premium	-
2023-08-24	Premium	sold	Premium	Premium	Premium	-
2023-06-01	Premium	acquired	Premium	Premium	Premium	-
2023-06-01	Premium	sold (taxes)	Premium	Premium	Premium	-
2023-06-01	Premium	sold	Premium	Premium	Premium	-
2023-05-31	Premium	acquired	Premium	Premium	Premium	-
2023-05-31	Premium	sold (taxes)	Premium	Premium	Premium	-
2023-05-31	Premium	sold	Premium	Premium	Premium	-
2023-05-30	Premium	sold	Premium	Premium	Premium	-
2023-05-24	Premium	sold	Premium	Premium	Premium	PRESIDENT & CEO
2023-05-24	Premium	sold (taxes)	Premium	Premium	Premium	PRESIDENT & CEO
2023-05-24	Premium	acquired	Premium	Premium	Premium	PRESIDENT & CEO

XENE - Xenon Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for XENE